164 related articles for article (PubMed ID: 4402099)
1. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
Khanna NK
Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
[No Abstract] [Full Text] [Related]
2. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
Mazurkiewicz-Kwilecki IM; Romagnoli A
J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
[No Abstract] [Full Text] [Related]
3. Cardiac toxicity of -lytic drugs.
Roba J
Arch Int Pharmacodyn Ther; 1972 Apr; 196():Suppl 196:120-. PubMed ID: 4403294
[No Abstract] [Full Text] [Related]
4. Effect of propranolol upon the hemoglobin-oxygen dissociation curve.
Pendleton RG; Newman DJ; Sherman SS; Brann EG; Maya WE
J Pharmacol Exp Ther; 1972 Mar; 180(3):647-56. PubMed ID: 4401159
[No Abstract] [Full Text] [Related]
5. Mechanism of anti-inflammatory activity of -adrenoceptor blocking agents.
Bhalla TN; Sinha JN; Tangri KK; Bhargava KP
Eur J Pharmacol; 1972 Dec; 20(3):366-8. PubMed ID: 4404943
[No Abstract] [Full Text] [Related]
6. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
Range H; Bischoff M; Siess M
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
[No Abstract] [Full Text] [Related]
7. Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
Klinge EA
Eur J Pharmacol; 1971 Apr; 14(2):124-9. PubMed ID: 4151170
[No Abstract] [Full Text] [Related]
8. Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Hellenbrecht D; Lemmer B; Wiethold G; Grobecker H
Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(2):211-26. PubMed ID: 4145013
[No Abstract] [Full Text] [Related]
9. [Effect of six adrenergic beta receptor blockaders on auriculo-ventricular conduction in the dog].
Giudicelli JF; Boissier JR
Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):287-92. PubMed ID: 4402114
[No Abstract] [Full Text] [Related]
10. [Effects of a few -sympatholytics (propranolol, C.39'089-Ba, H56-28 and Ko 592) on serum cholinesterase of rats].
Marmo E
Jpn J Pharmacol; 1971 Jun; 21(3):421-3. PubMed ID: 4397670
[No Abstract] [Full Text] [Related]
11. Beta-blocking drugs and human platelet aggregation in vitro.
Gibelli A; Montanari C; Bellani D; Mandelli V; Sacchetti G
Experientia; 1973 Feb; 29(2):186-7. PubMed ID: 4144249
[No Abstract] [Full Text] [Related]
12. The effect of some beta-adrenergic blocking and other drugs on brain lactate levels following electroshock.
Leonard BE
Neuropharmacology; 1971 Jul; 10(4):517-20. PubMed ID: 5094312
[No Abstract] [Full Text] [Related]
13. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
Alexandre JM; Menard J; Chevillard C; Schmitt H
Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
[No Abstract] [Full Text] [Related]
14. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
Aquaro G; Baduini G; Pavia M; Poletti T
Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
[No Abstract] [Full Text] [Related]
15. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
Hashimoto K; Endoh M; Tamura K; Taira N
Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
[No Abstract] [Full Text] [Related]
16. [Experimental research on the action of beta-adrenergic receptor blocking agents].
Valora N; Fidanza A; Floridi S
Arch Fisiol; 1969 Dec; 67(3):251-72. PubMed ID: 4394262
[No Abstract] [Full Text] [Related]
17. Action of some -blockers on plasma fibrinolysis in vitro and in vivo in man.
Ponari O; Civardi E; Potì R
Arzneimittelforschung; 1972 Mar; 22(3):629-31. PubMed ID: 4402605
[No Abstract] [Full Text] [Related]
18. Potentiation of bronchomotor responses by beta adrenergic antagonists.
Diamond L
J Pharmacol Exp Ther; 1972 Jun; 181(3):434-45. PubMed ID: 4402373
[No Abstract] [Full Text] [Related]
19. An experimental study of the beta-receptor blocking agents on the cardiac performance in dogs.
Singh N; Srivastava RK; Kulshrestha VK; Sinha JN; Kohli RP; Bhargava KP
Jpn J Pharmacol; 1970 Dec; 20(4):467-72. PubMed ID: 4395619
[No Abstract] [Full Text] [Related]
20. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
Okuda K; Chiba S; Taira N; Hashimoto K
Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
